{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T17:08:43Z","timestamp":1721581723456},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T00:00:00Z","timestamp":1388793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11033-013-2914-7","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T11:20:03Z","timestamp":1388748003000},"page":"751-756","source":"Crossref","is-referenced-by-count":13,"title":["Toremifene and tamoxifen have similar efficacy in the treatment of patients with breast cancer: a meta-analysis of randomized trials"],"prefix":"10.1007","volume":"41","author":[{"given":"Qian-ling","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-min","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,4]]},"reference":[{"key":"2914_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:1\u201315","journal-title":"Lancet"},{"key":"2914_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.1995.13.2.513","volume":"13","author":"IA Jaiyesimi","year":"1995","unstructured":"Jaiyesimi IA, Buzdar AU, Decker DA, Hortobagyi GN (1995) Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13:513\u2013529","journal-title":"J Clin Oncol"},{"key":"2914_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0305-7372(02)00036-1","volume":"28","author":"M Clemons","year":"2002","unstructured":"Clemons M, Danson S, Howell A (2002) Tamoxifen (\u2018Nolvadex\u2019): a review. Cancer Treat Rev 28:165\u2013180","journal-title":"Cancer Treat Rev"},{"key":"2914_CR4","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 351:1451\u20131467","journal-title":"Lancet"},{"key":"2914_CR5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687\u20131717","journal-title":"Lancet"},{"key":"2914_CR6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371\u20131388","journal-title":"J Natl Cancer Inst"},{"key":"2914_CR7","unstructured":"Tamoxifen information: reducing the incidence of breast cancer in women at high risk. http:\/\/www.fda.gov\/cder\/news\/tamoxifen\/ . Accessed 3 July 2007"},{"key":"2914_CR8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJM199811263392207","volume":"339","author":"CK Osborne","year":"1998","unstructured":"Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609\u20131618","journal-title":"N Engl J Med"},{"key":"2914_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00306737","volume":"17","author":"L Kangas","year":"1986","unstructured":"Kangas L, Kallio S, Blanco G, Gr\u00f6nroos M, Kallio S, Karjalainen A, Peril\u00e4 M, S\u00f6dervall M, Toivola R (1986) A new triphenylethylene compound, FC-1157a. II. Antitumor effects. Cancer Chemother Pharmacol 17:109\u2013113","journal-title":"Cancer Chemother Pharmacol"},{"key":"2914_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/02841869209088894","volume":"31","author":"L Kangas","year":"1992","unstructured":"Kangas L (1992) Agonistic and antagonistic effects of antiestrogens in different target organs. Acta Oncol 31:143\u2013146","journal-title":"Acta Oncol"},{"key":"2914_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-4731(90)90005-D","volume":"36","author":"E Salle di","year":"1990","unstructured":"di Salle E, Zaccheo T, Ornati G (1990) Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat. J Steroid Biochem 36:203\u2013206","journal-title":"J Steroid Biochem"},{"key":"2914_CR12","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/jnci\/85.17.1412","volume":"85","author":"AM Warri","year":"1993","unstructured":"Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL (1993) Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85:1412\u20131418","journal-title":"J Natl Cancer Inst"},{"key":"2914_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1524-4741.2002.08204.x","volume":"8","author":"PAA Hirsimaki","year":"2002","unstructured":"Hirsimaki PAA, Mantyla E (2002) Toxicity of antiestrogens. Breast J 8:92\u201396","journal-title":"Breast J"},{"key":"2914_CR14","first-page":"247","volume":"20","author":"Y Nomura","year":"1993","unstructured":"Nomura Y, Tominaga T, Abe O, Izuo M, Ogawa N (1993) Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer\u2014a comparative study by a double blind method with tamoxifen. Gan To Kagaku Ryoho 20:247\u2013258","journal-title":"Gan To Kagaku Ryoho"},{"key":"2914_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00662401","volume":"25","author":"LE Stenbygaard","year":"1993","unstructured":"Stenbygaard LE, Herrstedt J, Thomsen JF, Svendsen KR, Engelholm SA, Dombernowsky P (1993) Toremifene and tamoxifen in advanced breast cancer-a double-blind cross-over trial. Breast Cancer Res Treat 25:57\u201363","journal-title":"Breast Cancer Res Treat"},{"key":"2914_CR16","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1200\/JCO.1995.13.10.2556","volume":"13","author":"DF Hayes","year":"1995","unstructured":"Hayes DF, Van Zyl JA, Hacking A, Goedhals L, Bezwoda WR, Mailliard JA, Jones SE, Vogel CL, Berris RF, Shemano I, Schoenfelder J (1995) Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol 13:2556\u20132566","journal-title":"J Clin Oncol"},{"key":"2914_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1005891506092","volume":"45","author":"M Gershanovich","year":"1997","unstructured":"Gershanovich M, Garin A, Baltina D, Kurvet A, Kangas L, Ellm\u00e9n J (1997) A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group. Breast Cancer Res Treat 45:251\u2013262","journal-title":"Breast Cancer Res Treat"},{"key":"2914_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1997.375","volume":"76","author":"S Pyrh\u00f6nen","year":"1997","unstructured":"Pyrh\u00f6nen S, Valavaara R, Modig H, Pawlicki M, Pienkowski T, Gundersen S, Bauer J, Westman G, Lundgren S, Blanco G, Mella O, Nilsson I, Hietanen T, Hindy I, Vuorinen J, Hajba A (1997) Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the \u2018nordic\u2019 phase III study. Br J Cancer 76:270\u2013277","journal-title":"Br J Cancer"},{"key":"2914_CR19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1006440802709","volume":"65","author":"A Milla-Santos","year":"2001","unstructured":"Milla-Santos A, Milla L, Rallo L, Solano V (2001) Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer. Breast Cancer Res Treat 65:119\u2013124","journal-title":"Breast Cancer Res Treat"},{"key":"2914_CR20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/annonc\/mdh463","volume":"15","author":"O Pagani","year":"2004","unstructured":"International Breast Cancer Study Group, Pagani O, Gelber S, Price K, Zahrieh D, Gelber R, Simoncini E, Castiglione-Gertsch M, Coates AS, Goldhirsch A (2004) Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93. Ann Oncol 15:1749\u20131759","journal-title":"Ann Oncol"},{"key":"2914_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ejca.2008.10.011","volume":"45","author":"L Gianni","year":"2009","unstructured":"Gianni L, Gelber S, Ravaioli A, Price KN, Panzini I, Fantini M, Castiglione-Gertsch M, Pagani O, Simoncini E, Gelber RD, Coates AS, Goldhirsch A (2009) Second non-breast primary cancer following adjuvant therapy for early breast cancer: a report from the International Breast Cancer Study Group. Eur J Cancer 45:561\u2013571","journal-title":"Eur J Cancer"},{"key":"2914_CR22","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/cncr.24962","volume":"116","author":"JD Lewis","year":"2010","unstructured":"Lewis JD, Chagpar AB, Shaughnessy EA, Nurko J, McMasters K, Edwards MJ (2010) Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer. Cancer 116:2307\u20132315","journal-title":"Cancer"},{"key":"2914_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"2914_CR24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"2914_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"2914_CR26","first-page":"15","volume":"8","author":"A Tobias","year":"1999","unstructured":"Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15\u201317","journal-title":"Stata Tech Bull"},{"key":"2914_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"issue":"Suppl","key":"2914_CR28","first-page":"S41","volume":"16","author":"SO Pyrh\u00f6nen","year":"1990","unstructured":"Pyrh\u00f6nen SO (1990) Phase III studies of toremifene in metastatic breast cancer. Breast Cancer Res Treat 16(Suppl):S41\u2013S46","journal-title":"Breast Cancer Res Treat"},{"key":"2914_CR29","first-page":"587","volume":"43","author":"ML Gershanovich","year":"1997","unstructured":"Gershanovich ML, Garin AM, Baltinia D, Kurvet A, Kangas L, Ellmen Iu (1997) Results of phase II clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women. Vopr Onkol 43:587\u2013595","journal-title":"Vopr Onkol"},{"issue":"Suppl 6","key":"2914_CR30","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0959-8049(02)00279-4","volume":"38","author":"K Holli","year":"2002","unstructured":"Holli K, Finnish Breast Cancer Group (2002) Tamoxifen versus toremifene in the adjuvant treatment of breast cancer. Eur J Cancer 38(Suppl 6):S37\u2013S38","journal-title":"Eur J Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2914-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2914-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2914-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T19:47:52Z","timestamp":1565034472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2914-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["2914"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2914-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,4]]}}}